Sam Bresnick testified before the Senate Judiciary Subcommittee on Privacy, Technology, and the Law regarding tech companies' ties to China and their implications in a future conflict scenario.

This publication examines how emerging AI tools—including LLM-based chatbots and biological design tools—are reshaping the biosecurity landscape for commercial DNA synthesis.

In February 2024, CSET introduced its new cybersecurity jobs dataset, a novel resource comprising ~1.4 million LinkedIn profiles of current U.S. cybersecurity workers. This data snapshot uses the dataset to identify top-producing institutions of cybersecurity talent.

Medical artificial intelligence, which depends on large repositories of biological data, can improve public health and contribute to the growing global bioeconomy. Countries that strategically prioritize medical AI could benefit from a competitive advantage and set global norms. This report examines China’s stated goals for medical AI, finding that the country’s strategy for biodata collection and medical AI development positions it to be an economic and technological leader in this sector.

As the U.S. government considers banning genomics companies from China, it opens a broader question about how the United States and other market economies should deal with China’s “national champions.” This paper provides an overview of one such company—BGI—and how China’s industrial policy impacts technology development in China and around the world.

China’s brain-computer interface research has two dimensions. Besides its usual applications in neuropathology, China is extending the benefits of BCI to the general population, aiming at enhanced cognition and a “merger” of natural and artificial intelligence. This report, authored in collaboration with researchers from the Department of War Studies at King’s College London uses bibliometric analysis and expert assessment of technical documents to evaluate China’s BCI, and conclude that the research is on track to achieve its targets.

This data snapshot is the first in a series on CSET’s cybersecurity jobs data, a new dataset created by classifying data from 513 million LinkedIn user profiles. Here, we offer an overview of its creation and explore some use cases for analysis.

Understanding the current state of the AI workforce is essential as the U.S. prepares an AI-ready workforce. This Data Snapshot provides the latest estimates for the AI workforce by using data from the U.S. Census Bureau’s 2022 American Community Survey. It also highlights the changes in size and composition of the AI workforce since our earlier analysis of data from 2018.

CSET submitted the following comment in response to a DHS Notice on Proposed Rule-Making from the U.S. Citizenship and Immigration Services about modernizing H-1B requirements, providing flexibility in the F-1 program, and program improvements affecting other nonimmigrant workers

Recent government directives, international conferences, and media headlines reflect growing concern that artificial intelligence could exacerbate biological threats. When it comes to biorisk, AI tools are cited as enablers that lower information barriers, enhance novel biothreat design, or otherwise increase a malicious actor’s capabilities. In this explainer, CSET Biorisk Research Fellow Steph Batalis summarizes the state of the biorisk landscape with and without AI.